Pharmacokinetics and tolerance of mycophenolate mofetil in renal transplant children

Pediatric Nephrology

Volumn 14, Issue 2, 2000, Pages 95-99

  Jacqz Aigrain, Evelyne ^a   Khan Shaghaghi, Elisabeth ^a   Baudouin, Véronique ^a   Popon, Michel ^a   Zhang, Daolun ^a   Maisin, Anne ^a   Loirat, Chantal ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Mycophenolate mofetil; Pharmacokinetics; Toxicity; Transplantation

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG ABSORPTION; DRUG BLOOD LEVEL; GASTROINTESTINAL SYMPTOM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY GRAFT; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0033951582     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670050020     Document Type: Article

References (17)

1. Lee WA, Gu L, Miksztal AR, Chu N, Leung K, Nelson PH (1990) Bioavailability improvement of mycophenolic acid through amino ester derivatization. Pharm Res 7:161
2. Allison AC, Eugui EM (1993) Immunosuppressive and other effects of mycophenolate acid and an ester prodrug, mycophenolate mofetil. Immunol Rev 136:5-28
3. Carr SF, Papp E, Wu JC, Natsumeda Y (1993) Characterization of human type I and II IMP dehydrogenases. J Biol Chem 268:27286-27290
4. Wu JC (1994) Mycophenolate mofetil: molecular mechanisms of action. Perspect Drug Discov Design 2:185-204
5. European Mycophenolate Mofetil Study Group (1995) Placebo controlled study mycophenolate combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 345:1321-1325
6. Sollinger HW for the US Renal Transplant Mycophenolate Mofetyl Study Group (1995) Mycophenolate mofetyl for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 60:225-232
7. Tricontinental Mycophenolate Mofetyl Renal Transplantation Study Group (1996) A blinded, randomized clinical trial of mycophenolate mofetyl for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 61:1029-1037
8. nd International Congress on Paediatric Transplantation, 22-24 August 1996, Paris, France, C39-S13
9. Ettenger R, Cohen A, Nast C, Moulton L, Marik J, Gales B (1997) Mycophenolate mofetil as maintenance immunosuppression in pediatric renal transplantation. Transplant Proc 29:340-341
10. Tsina I, Chu F, Hama K, Kaloostian M, Ling Tam Y, Tarnowski T, Wong B (1996) Manual and automated (robotic) high-performance liquid chromatography methods for the determination of mycophenolate acid and its glucuronide conjugate in human plasma. J Chromatogr Biomed Appl 675:119-129
11. The Mycophenolate Mofetyl Renal Refractory Rejection Study Group (1996) Mycophenolate mofetyl for the treatment of refractory acute, cellular renal transplant rejection. Transplantation 61:722-729
12. Bullingham R, Monroe S, Nicholls A, Hale M (1996) Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration. J Clin Pharmacol 36:315-324
13. Bullingham RES, Nicholls A, Hale M (1996) Pharmacokinetics of mycophenolate mofetil (RS61443): a short review. Transplant Proc 28:925-929
14. Fulton B, Markham A (1996) Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation. Drugs 51:278-298
15. Zucker K, Rosen A, Tsaroucha A, DeFaria L, Roth D, Ciancio G, Esquenazi V, Burke G, Tzakis A, Miller J (1997) Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy and analogous in vitro findings. Transpl Immunol 5:225-232
16. Bullingham RES, Nicholls AJ, Kamm BR (1998) Clinical pharmacokinetics of mycophenolate mofetil. Clin Pharmacokinet 34:429-455
17. Filler G, Ehrich J (1997) Mycophenolate mofetil for rescue therapy in acute renal transplant rejection in children should always be monitored by measurement of trough concentration. Nephrol Dial Transplant 12:374-375